Pathology
 |
|
18 may 2019 00:02:02 |
| A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma (Bone Marrow Transplantation) |
|
Tweet |
| 55 viewsCategory: Medicine, Pathology |
 Direct adjusted survival and cumulative incidence curves for observational studies (Bone Marrow Transplantation)Oral Candidal carriage and associated risk indicators among adults in Sakaka, Saudi Arabia (BMC Oral Health) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
